Insider Selling: Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Sells $263,588.40 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) CFO Benjamin Hohl sold 6,018 shares of the company’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $43.80, for a total transaction of $263,588.40. Following the sale, the chief financial officer directly owned 51,000 shares in the company, valued at approximately $2,233,800. This trade represents a 10.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Price Performance

NYSEARCA:IMRA traded up $0.41 on Monday, reaching $17.64. 617 shares of the company’s stock were exchanged, compared to its average volume of 5,386. The firm has a market cap of $3.35 million, a price-to-earnings ratio of 352.80 and a beta of 2.88. Bitwise MARA Option Income Strategy ETF has a 52 week low of $11.99 and a 52 week high of $54.94. The stock has a fifty day simple moving average of $16.49 and a 200-day simple moving average of $15.80.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.